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Abstract A set of novel Schiff bases of isatin were syn-
thesized and characterized by reaction of isatin with various
aromatic or heterocyclic primary amines. Cytotoxic activi-
ties for some of the synthesized compounds were evaluated
byMTT assay in three human cancer cell lines (HeLa, LS180
and Raji). Half of the tested compounds showed good
cytotoxicity in HeLa cells. 3-(2-(4-nitrophenyl) hydrazono)
indolin-2-one was found to be the most potent molecule
among the studied isatin derivatives. Docking studies of
3-substituted indolin-2-one scaffolds on vascular endothelial
growth factor receptor 2 (VEGFR-2) involved in cell pro-
liferation and angiogenesis was performed. 3-(naphthalen-1-
ylimino) indolin-2-one and 3-(2-(4-nitrophenyl) hydrazono)
indolin-2-one exhibited higher docking binding energies
with receptor. For 3-(2-(4-nitrophenyl) hydrazono) indolin-
2-one, H-bond interaction with Cys917 residue of target
active site was in common with reported crystallographic
benzoimidazole derivative (PDB code: 2OH4). New key
H-bonds involving Glu915, Asn921, and Arg1049 residues
in VEGFR-2 active site could be detected for 3-(2-(4-
nitrophenyl) hydrazono) indolin-2-one. Extended lipophilic
rings containing H-bond acceptors on the 3 position of ind-
oline scaffold seemed to be important factors in developing
potent VEGFR-2 inhibitors virtually. Based on the ligand
efﬁciency indices, some isoxazole or thiazole substituted
isatin derivatives may be regarded as efﬁcient candidates for
further molecular developments of anticancer agents.
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Introduction
Isatin is an endogenous compound isolated in 1988 (Glover
et al., 1988) and reported to possess a wide range of central
nervous system activities (d’Ischia et al., 1988; Varma and
Nobles, 1975). It has also been found as a metabolic
derivative of adrenaline in humans (d’Ischia et al., 1988).
Isatin is a natural product found in a number of plants
including those of the genus isatis and also has been found
as a metabolic derivative of humans (d’Ischia et al., 1988).
Various derivatives of isatin are known to possess a wide
range of pharmacological properties (Varma and Nobles,
1975; Varma and Khank, 1977). Among the important
pharmacological effects, antibacterial (Pandeya et al.,
2000, 1999a; Sarangapani and Reddy, 1994; Varma and
Nobles, 1975; Sridhar et al., 2001), antifungal (Pandeya
et al., 2000; Pandeya et al., 1999), antiviral (Varma and
Nobles, 1967; Singh et al., 1983; Logan et al., 1975), and
anti-HIV (Pandeya et al., 1999b; Pandeya et al., 2000)
activities are worth noting. Within the context of enzyme
inhibitors, isatins (also known as 2,3-dioxindoles) have
seen recent applications in the inhibition of cysteine and
serine proteases (Iyer and Hanna, 1995; Webber et al.,
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